The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.
Enforcement Report - Week Of June 01, 2022
NORFOLK, Va., Oct. 7, 2021 /PRNewswire/ -- Real World Medical Data Solutions, Inc., a novel supplement company founded by Cardiologist Dr. Mark East, announced today the launch of its product MASTER Vitamins™ with Immune Health. MASTER Vitamins™ was developed in response to a vital need for patients to enhance their immune function in light of the COVID-19 pandemic. The supplement is formulated to contain optimal amounts of Vitamin C, Vitamin D3, L-Methylfolate, Zinc, Magnesium, Taurine, and Alpha-lipoic acid.*
Enforcement Report - Week of April 25, 2018
Enforcement Report - Week of May 24, 2017
The takeover of Encore gives Novartis rights to EV06 (lipoic acid choline ester), a disease-modifying treatment for age-related loss of near distance vision (presbyopia) that can be delivered in an eyedrop formulation. Presbyopia affects 80% of people aged over 45 and makes everyday tasks such as reading challenging.